Sort
10,766 grants matching “checkpoint inhibitor”
Targeting Unique Meyloid Populations to Overcome Anti-PD-1 Resistance Conferred by Specific Cancer Mutations
$194,589Brian C Miller · Univ Of North Carolina Chapel Hill · K08 · FY2021 · CA
Liquid Biopsy Core
$194,588Amir Goldkorn · University Of Southern California · P30 · FY2024 · CA
Developing BRAF mutant and BRAF wild-type selective strategies for radiosensitization in Anaplastic Thyroid Cancer
$194,528Terence Marques Williams · Beckman Research Institute/City Of Hope · R01 · FY2024 · CA
Anti-tumor efficacy of novel cGAS-STING pathway agonists
$194,526Victor Robert Defilippis · Oregon Health & Science University · R21 · FY2021 · CA
Tumor-directed immunostimulatory nanoparticles for novel 'prime-pull'cancer vaccination
$194,524Prabhani Atukorale · University Of Massachusetts Amherst · K22 · FY2021 · CA
Tumor-directed immunostimulatory nanoparticles for novel 'prime-pull'cancer vaccination
$194,308Prabhani Atukorale · University Of Massachusetts Amherst · K22 · FY2022 · CA
B7-H3 in Medulloblastoma: evaluating its expression and function to harness new therapeutic targets
$194,184Allison M. Martin · Albert Einstein College Of Medicine · K08 · FY2022 · NS
B7-H3 in Medulloblastoma: evaluating its expression and function to harness new therapeutic targets
$194,184Allison M. Martin · Albert Einstein College Of Medicine · K08 · FY2021 · NS
B7-H3 in Medulloblastoma: evaluating its expression and function to harness new therapeutic targets
$194,184Allison M. Martin · Albert Einstein College Of Medicine · K08 · FY2020 · NS
Novel targets of treatment for NF1-mutant melanoma
$194,142Iman Osman · New York University School Of Medicine · R21 · FY2022 · CA
Tumor-directed immunostimulatory nanoparticles for novel 'prime-pull'cancer vaccination
$194,090Prabhani Atukorale · University Of Massachusetts Amherst · K22 · FY2023 · CA
Enhancing precision medicine for brain metastases using interpretable and integrative deep learning
$194,022Albert Kim · Massachusetts General Hospital · K08 · FY2025 · EB
Combinatorial Approaches to Overcoming Resistance to BRAF(V600E) Targeted Thera
$193,972David E Fisher · Massachusetts General Hospital · P01 · FY2014 · CA
Cellular responses to DNA replication stress
$193,884Marcus Smolka · Cornell University · R01 · FY2018 · GM
Cervical cancer derived xenografts (PDX) and organoid raft cultures to evaluate pathway specific therapeutic agents.
$193,793Nilam Sanjib Banerjee · University Of Alabama At Birmingham · R21 · FY2019 · CA
Developing BRAF mutant and BRAF wild-type selective strategies for radiosensitization in Anaplastic Thyroid Cancer
$193,780Terence Marques Williams · Ohio State University · R01 · FY2020 · CA
Drg1: A Novel Molecular Target for Cancer Therapy
$193,563Sloan-Kettering Institute For Cancer Res · R01 · FY2002 · CA
TARGETING ORIGINS OF REPLICATION WITH CANCER DRUGS
$193,500Roswell Park Cancer Institute Corp · R01 · FY2002 · CA
Disconnecting CR2/CD21 from Its C3d Ligand to Ameliorate Lupus
$193,489V Michael Holers · University Of Colorado Denver · R21 · FY2014 · AI
Project 1 Genetic and Immunologic Mechanisms Underlying Combination Sacituzumab plus Radiation Therapy for Bladder Cancer
$193,244Timothy An-Thy Chan · Cleveland Clinic Lerner Com-Cwru · U54 · FY2025 · CA
Project 1 Genetic and Immunologic Mechanisms Underlying Combination Sacituzumab plus Radiation Therapy for Bladder Cancer
$193,243Timothy An-Thy Chan · Cleveland Clinic Lerner Com-Cwru · U54 · FY2022 · CA
Identifying Therapeutic Vulnerabilities of c-MYC-driven Small Cell Lung Cancer
$193,042Trudy Gale Oliver · University Of Utah · R21 · FY2019 · CA
Defining and targeting the immune-suppressive metabolic microenvironment of leptomeningeal melanoma metastases
$192,997Inna Smalley · H. Lee Moffitt Cancer Ctr & Res Inst · R21 · FY2023 · CA
Airway Immune Response in Critically Ill Children-Precision Medicine in Children At Risk for Acute Respiratory Distress Syndrome
$192,672Jocelyn Rebecca Grunwell · Emory University · K23 · FY2020 · HL
Mechanism-Based Use of Chk1 Inhibitors in Pancreas Cancer
$192,653Jonathan Maybaum · University Of Michigan At Ann Arbor · R01 · FY2015 · CA